Daniel Ehrlich
Daniel Ehrlich, from Indianapolis, IN, is pursuing a B.S. in Computer Science and Chemistry, with minors in Financial Economics and Global Health, at Duke University. Throughout his time as an undergraduate, Daniel has researched environmental health exposures under Professor Heather Stapleton, with a primary focus on per- and polyfluoroalkyl substances (PFAS). For his senior thesis, he joined the North Carolina Firefighter Cancer Cohort Study to characterize PFAS exposure in firefighters and identify occupational hazards. Concurrently, Daniel has worked under Dr. Nicole Kleinstreuer, acting deputy director of the National Institutes of Health (NIH), to advance the development of new approach methodologies, specifically applying computational methods to assess cardiotoxicity and model VEGF-mediated atherosclerosis.
At Duke, Daniel has served as an ambassador for the university president and sat on the young trustee nominating committee for Duke’s Board of Trustees. He has also engaged in pro-bono consulting for startups through the Tamid group, travelled to the Seychelles to assist in marine conservation efforts, and worked as a project analyst to advance solar development initiatives in the southeastern US. Additionally, Daniel volunteers with New Neighbors, tutoring children from refugee families in the Durham-Chapel Hill area, and serves as a counselor for Camp Kesem, supporting children whose parents have been affected by cancer.
Driven by a vision to transform precision medicine, Daniel is interested in applying his diverse skillset to the emerging field of RNA therapeutics. By improving safety and efficacy, Daniel seeks to make these groundbreaking therapies more accessible, particularly in low- and middle-income countries, where advanced medical treatments are often out of reach. As a Marshall Scholar, Daniel plans to pursue a PhD in Biological Sciences at the MRC Toxicology Unit at the University of Cambridge.